Port Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$557K Buy
1,134
+25
+2% +$13.6K 0.02% 65
2025
Q4
$643K Sell
1,109
-25
-2% -$14.1K 0.03% 62
2025
Q3
$550K Sell
1,134
-17
-1% -$7.91K 0.02% 66
2025
Q2
$467K Buy
1,151
+30
+3% +$12.5K 0.02% 67
2025
Q1
$558K Sell
1,121
-264
-19% -$143K 0.03% 65
2024
Q4
$721K Buy
1,385
+22
+2% +$12.1K 0.03% 62
2024
Q3
$843K Sell
1,363
-201
-13% -$119K 0.04% 55
2024
Q2
$865K Sell
1,564
-46
-3% -$26.4K 0.04% 53
2024
Q1
$936K Buy
1,610
+239
+17% +$134K 0.05% 51
2023
Q4
$728K Sell
1,371
-2
-0.1% -$968 0.04% 58
2023
Q3
$695K Sell
1,373
-118
-8% -$62.9K 0.04% 54
2023
Q2
$778K Buy
+1,491
New +$805K 0.05% 52
2021
Q4
Sell
-3,491
Closed -$2M 86
2021
Q3
$2M Sell
3,491
-17
-0.5% -$9.33K 0.1% 43
2021
Q2
$1.77M Buy
3,508
+16
+0.5% +$7.55K 0.09% 45
2021
Q1
$1.59M Buy
3,492
+9
+0.3% +$4.3K 0.09% 46
2020
Q4
$1.62M Buy
+3,483
New +$1.63M 0.11% 47

Other funds holding TMO

Port Capital's TMO Position: Q1 2026 in Review

Port Capital increased its Thermo Fisher Scientific (TMO) stake by 2.3% in Q1 2026, buying an estimated $13.6K and bringing the position to 1,134 shares worth $557K. The position accounts for 0.02% of the portfolio, ranked #65.

Port Capital first reported a position in TMO in Q4 2020 and has held it in 16 quarters since. The position peaked at $2M in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Port Capital held 1,134 shares of Thermo Fisher Scientific worth $557K as of Q1 2026.
  • Port Capital bought 25 Thermo Fisher Scientific shares in Q1 2026, an estimated $13.6K.
  • Thermo Fisher Scientific made up 0.02% of Port Capital's portfolio in Q1 2026, its #65 holding.
  • Port Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 16 quarters since.
  • Port Capital's Thermo Fisher Scientific position peaked at $2M in Q3 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Port Capital's 13F filing for Q1 2026, filed 15 May 2026.